Exact Mass: 415.0125

Exact Mass Matches: 415.0125

Found 49 metabolites which its exact mass value is equals to given mass value 415.0125, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

2-(4-bromophenyl)-6-(4-methoxyphenyl)-4-phenylpyridine

2-(4-bromophenyl)-6-(4-methoxyphenyl)-4-phenylpyridine

C24H18BrNO (415.0572)


   
   
   

Maybridge4_001067

Maybridge4_001067

C16H17NO8S2 (415.0396)


   
   

dihydrodiscorhabdin B

dihydrodiscorhabdin B

C18H14BrN3O2S (414.999)


   

Sinigrin

potassium (E)-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-ylthio)but-3-enylideneamino sulfate hydrate

C10H18KNO10S2 (415.0009)


Sinigrin (hydrate) is a natural aliphatic glucosinolate present in plants of the Brassicaceae family. Sinigrin (hydrate) exhibits anti-cancer, antibacterial, antifungal, antioxidant and anti-inflammatory activities[1].

   

N-(3-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)(hydroxy)Methyl)-2,4-difluorophenyl)propane-1-sulfonamide

N-(3-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)(hydroxy)Methyl)-2,4-difluorophenyl)propane-1-sulfonamide

C17H16ClF2N3O3S (415.0569)


   

2,4-Pentanedione - indium (3:1)

2,4-Pentanedione - indium (3:1)

C15H24InO6 (415.0612)


   

Fmoc-D-2-Amino-4-bromo-4-pentenoic acid

Fmoc-D-2-Amino-4-bromo-4-pentenoic acid

C20H18BrNO4 (415.0419)


   

Fmoc-L-2-Amino-4-bromo-4-pentenoic acid

Fmoc-L-2-Amino-4-bromo-4-pentenoic acid

C20H18BrNO4 (415.0419)


   

4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide dihydrochloride

4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide dihydrochloride

C14H24BrCl2N3O2 (415.0429)


   

Benzyl 10-iodo-2-oxo-1-oxa-6-azaspiro[4.5]decane-6-carboxylate

Benzyl 10-iodo-2-oxo-1-oxa-6-azaspiro[4.5]decane-6-carboxylate

C16H18INO4 (415.0281)


   

N-[5-bromomethyl-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide

N-[5-bromomethyl-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide

C16H19BrFN3O2S (415.0365)


   
   

Benzenesulfonic acid,4-chloro-3-[4,5-dihydro-3-methyl-5-oxo-4-(2-phenyldiazenyl)-1H-pyrazol-1-yl]-,sodium salt (1:1)

Benzenesulfonic acid,4-chloro-3-[4,5-dihydro-3-methyl-5-oxo-4-(2-phenyldiazenyl)-1H-pyrazol-1-yl]-,sodium salt (1:1)

C16H13ClN4NaO4S+ (415.0244)


   

erbium acetate tetrahydrate

erbium acetate tetrahydrate

C6H17ErO10 (415.0125)


   

VO-Ohpic trihydrate

VO-Ohpic trihydrate

C12H16N2O11V (415.0194)


   

ethyl 5-(benzyloxy)-6-broMo-2-forMyl-1-Methyl-1H-indole-3-carboxylate

ethyl 5-(benzyloxy)-6-broMo-2-forMyl-1-Methyl-1H-indole-3-carboxylate

C20H18BrNO4 (415.0419)


   

ammonium bismuth citrate

ammonium bismuth citrate

C6H8BiNO7 (415.0105)


   

4-[2-[(3,4-Dichlorophenyl)methylthio]-6-[(methylthio)methyl]-4-pyrimidinyl]morpholine

4-[2-[(3,4-Dichlorophenyl)methylthio]-6-[(methylthio)methyl]-4-pyrimidinyl]morpholine

C17H19Cl2N3OS2 (415.0347)


   

2-thiophen-2-yl-N-[5-[[4-(trifluoromethyl)phenyl]methylthio]-1,3,4-thiadiazol-2-yl]acetamide

2-thiophen-2-yl-N-[5-[[4-(trifluoromethyl)phenyl]methylthio]-1,3,4-thiadiazol-2-yl]acetamide

C16H12F3N3OS3 (415.0095)


   
   
   

4-deoxy-beta-L-erythro-hex-4-enopyranuronosyl-(1,4)-D-N-sulfoglucosamine

4-deoxy-beta-L-erythro-hex-4-enopyranuronosyl-(1,4)-D-N-sulfoglucosamine

C12H17NO13S-2 (415.0421)


   

2-(5-Bromo-3-nitro-1,2,4-triazol-1-YL)-N-(diphenylmethyl)acetamide

2-(5-Bromo-3-nitro-1,2,4-triazol-1-YL)-N-(diphenylmethyl)acetamide

C17H14BrN5O3 (415.028)


   

N-[(1E)-(5-bromo-2-hydroxyphenyl)methylene]-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetohydrazide

N-[(1E)-(5-bromo-2-hydroxyphenyl)methylene]-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetohydrazide

C19H18BrN3O3 (415.0531)


   
   

1-(2-chlorophenyl)-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-3-methyl-5-thieno[2,3-c]pyrazolecarboxamide

1-(2-chlorophenyl)-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-3-methyl-5-thieno[2,3-c]pyrazolecarboxamide

C18H14ClN5OS2 (415.0328)


   

2-(2,6-Dichlorophenyl)-3-(4-methyl-6-phenyl-pyrimidin-2-yl)thiazolidin-4-one

2-(2,6-Dichlorophenyl)-3-(4-methyl-6-phenyl-pyrimidin-2-yl)thiazolidin-4-one

C20H15Cl2N3OS (415.0313)


   

2-chloro-4-fluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide

2-chloro-4-fluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide

C16H9ClF7NO2 (415.021)


   

1-[(4-bromophenyl)methyl]-3-(4-chlorophenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-1-ium

1-[(4-bromophenyl)methyl]-3-(4-chlorophenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-1-ium

C21H21BrClN2+ (415.0577)


   

3-[(2-Bromo-6,11-dihydrobenzo[c][1]benzothiepin-11-yl)oxy]-1-azabicyclo[2.2.2]octane

3-[(2-Bromo-6,11-dihydrobenzo[c][1]benzothiepin-11-yl)oxy]-1-azabicyclo[2.2.2]octane

C21H22BrNOS (415.0605)


   

N-(4-bromo-2-pyridinyl)-4-[(1-methyl-2-oxo-4-quinolinyl)oxy]butanamide

N-(4-bromo-2-pyridinyl)-4-[(1-methyl-2-oxo-4-quinolinyl)oxy]butanamide

C19H18BrN3O3 (415.0531)


   
   

2-[(5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid

2-[(5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid

C20H17NO5S2 (415.0548)


   

(S)-isoconazole cation

(S)-isoconazole cation

C18H15Cl4N2O+ (414.9938)


   

2-[(5E)-5-[(2,3-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid

2-[(5E)-5-[(2,3-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid

C20H17NO5S2 (415.0548)


   

TDP(3-)

TDP(3-)

C10H13N2O12P2 (414.9944)


The organophosphate oxoanion that is the trianion of TDP arising from deprotonation of the two diphosphate OH groups; major species at pH 7.3.

   

grixazone B(2-)

grixazone B(2-)

C18H13N3O7S (415.0474)


An L-alpha-amino-acid anion obtained by deprotonation of the two carboxy groups of grixazone B.

   

AMDE-1

AMDE-1

C18H8ClF6N3 (415.0311)


AMDE-1 is a potent autophagy inducer. AMDE-1 induces autophagy by the AMPK-mTORC1-ULK1 pathway and at the same time inhibited autophagy-mediated degradation by causing lysosome dysfunction. AMDE-1 can be used in research of cancer[1].

   

GOAT-IN-1

GOAT-IN-1

C18H13ClF3NO3S (415.0257)


GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT), which could be useful for the prophylaxis or treatment of obesity, diabetes, hyperlipidemia, metabolic, non-alcoholic fatty liver, steatohepatitis, sarcopenia, appetite control, alcohol/narcotic dependence, Alzheimer’s disease, Parkinson’s disease, cerebrovascular dementia, cerebral apoplexy, cerebral infarction, cardic disease, some kind of tumors.

   

5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,14(21),16-pentaene-6,13-dione

5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,14(21),16-pentaene-6,13-dione

C18H14BrN3O2S (414.999)


   

(3s,8r,10r)-5-bromo-13-hydroxy-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,13,15,17(21)-hexaen-6-one

(3s,8r,10r)-5-bromo-13-hydroxy-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,13,15,17(21)-hexaen-6-one

C18H14BrN3O2S (414.999)


   

10-[(5-bromo-6-hydroxy-2,3-dihydro-1-benzothiophen-2-yl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

10-[(5-bromo-6-hydroxy-2,3-dihydro-1-benzothiophen-2-yl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

C18H14BrN3O2S (414.999)


   

(3s,8r,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,14(21),16-pentaene-6,13-dione

(3s,8r,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,14(21),16-pentaene-6,13-dione

C18H14BrN3O2S (414.999)


   

(3s,10s)-5-bromo-13-hydroxy-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,13,15,17(21)-hexaen-6-one

(3s,10s)-5-bromo-13-hydroxy-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,13,15,17(21)-hexaen-6-one

C18H14BrN3O2S (414.999)